Asia Pacific pharmaceutical analytical testing outsourcing market will grow by 10.2% annually with a total addressable market cap of $30,233.3 million over 2022-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.
Highlighted with 31 tables and 50 figures, this 108-page report “Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Country.
Based on Service Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Bioanalytical Testing
o Clinical Testing
o Non-clinical Testing
• Method Development and Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Other Methods
• Stability Testing
o Drug Substances Testing
o Accelerated Stability Testing
o Photostability Testing
o Other Stability Testings
• Other Services
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Raw Materials & Additives
• Active Pharmaceutical Ingredients (APIs)
• Finished Products
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Other End Users
By Organization Size, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• SMEs
• Large Enterprises
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, End User and Organization Size over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Boston Analytical, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Exova Group PLC
Intertek Pharmaceutical Services
Laboratory Testing Inc.
Pace Analytical Services LLC
Pharmaceutical Product Development, LLC
SGS SA
Steris PLC
Tentamus
Toxikon Inc.
West Pharmaceutical Services Inc.
WuXi AppTec, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Service Type 40
3.1 Market Overview by Service Type 40
3.2 Bioanalytical Testing 42
3.2.1 Clinical Testing 43
3.2.2 Non-clinical Testing 44
3.3 Method Development and Validation 45
3.3.1 Extractable & Leachable 47
3.3.2 Impurity Method 48
3.3.3 Technical Consulting 49
3.3.4 Other Methods 50
3.4 Stability Testing 51
3.4.1 Drug Substances Testing 53
3.4.2 Accelerated Stability Testing 54
3.4.3 Photostability Testing 55
3.4.4 Other Stability Testings 56
3.5 Other Services 57
4 Segmentation of Asia Pacific Market by Product Type 58
4.1 Market Overview by Product Type 58
4.2 Raw Materials & Additives 60
4.3 Active Pharmaceutical Ingredients (APIs) 61
4.4 Finished Products 62
5 Segmentation of Asia Pacific Market by End User 63
5.1 Market Overview by End User 63
5.2 Pharmaceutical & Biopharmaceutical Companies 65
5.3 Contract Manufacturing Organizations (CMOs) 66
5.4 Other End Users 67
6 Segmentation of Asia Pacific Market by Organization Size 68
6.1 Market Overview by Organization Size 68
6.2 SMEs 70
6.3 Large Enterprises 71
7 Asia-Pacific Market 2021-2031 by Country 72
7.1 Overview of Asia-Pacific Market 72
7.2 Japan 75
7.3 China 78
7.4 Australia 81
7.5 India 83
7.6 South Korea 85
7.7 Rest of APAC Region 87
8 Competitive Landscape 89
8.1 Overview of Key Vendors 89
8.2 New Product Launch, Partnership, Investment, and M&A 92
8.3 Company Profiles 93
Boston Analytical, Inc. 93
Charles River Laboratories International, Inc. 95
Eurofins Scientific SE 96
Exova Group PLC 97
Intertek Pharmaceutical Services 98
Laboratory Testing Inc. 99
Pace Analytical Services LLC 100
Pharmaceutical Product Development, LLC 101
SGS SA 102
Steris PLC 103
Tentamus 104
Toxikon Inc. 105
West Pharmaceutical Services Inc. 106
WuXi AppTec, Inc. 107
RELATED REPORTS 108
List of Tables:
Table 1. Snapshot of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 21
Table 3. Worldwide Total Number of Registered Clinical Trials 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 32
Table 5. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 40
Table 6. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market: Bioanalytical Testing by Type, 2021-2031, $ mn 42
Table 7. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market: Method Development and Validation by Type, 2021-2031, $ mn 46
Table 8. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market: Stability Testing by Type, 2021-2031, $ mn 52
Table 9. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, $ mn 58
Table 10. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 63
Table 11. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 68
Table 12. APAC Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021-2031, $ mn 73
Table 13. Japan Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 77
Table 14. Japan Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 77
Table 15. Japan Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 77
Table 16. China Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 80
Table 17. China Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 80
Table 18. China Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 80
Table 19. Australia Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 82
Table 20. Australia Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 82
Table 21. Australia Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 82
Table 22. India Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 84
Table 23. India Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 84
Table 24. India Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 84
Table 25. South Korea Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 86
Table 26. South Korea Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 86
Table 27. South Korea Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 86
Table 28. Pharmaceutical Analytical Testing Outsourcing Market in Rest of APAC by Country/Region, 2021-2031, $ mn 88
Table 29. Boston Analytical, Inc.: Company Snapshot 93
Table 30. Boston Analytical, Inc.: Business Segmentation 94
Table 31. Boston Analytical, Inc.: Product Portfolio 94
